Santa Cruz Biotechnology supplies a comprehensive collection of Siglec-14 monoclonal antibodies for advanced research in immunology and cell biology. Siglec-14 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Siglec-14, a member of the sialic acid-binding immunoglobulin-like lectin family, plays a crucial role in modulating immune responses and maintaining homeostasis. It is primarily expressed on myeloid cells and is involved in the recognition of sialylated ligands, influencing cell signaling pathways and interactions. Understanding the function of Siglec-14 is essential for elucidating its role in immune regulation and potential implications in various diseases. Siglec-14 research has revealed significant insights into cellular communication and immune system regulation. Current investigations focus on understanding how Siglec-14 influences inflammatory responses and its potential role in disease development. Ongoing studies continue to uncover new aspects of Siglec-14 biology and its impact on human health. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of Siglec-14 and its impact on human health.